BioSpace News Archive

Drug Development

Virion Biotherapeutics Demonstrates Preclinical Proof-of-Concept for First Therapeutic Interfering Particle Candidate in Respiratory Virus Infections

--Data presented at 6th ISIVR-AVG Conference--

November 14, 2018
·
5 min read
Business

Valens Signs Multi-Year Cannabis Extraction and Product R&D Agreement With Harvest One

Valens GroWorks Corp. is pleased to announce that it has entered into a multi-year Extraction Services Agreement (the “Agreement”) with Harvest One (TSXV:HVT) for cannabis extraction and value-added services.

November 14, 2018
·
4 min read
Drug Development

Zymeworks Announces Updated Clinical Data for Novel Bispecific Antibody, ZW25, Presented at the EORTC-NCI-AACR Symposium

ZW25 Active and Well Tolerated Across Multiple HER2-expressing Tumor Types

November 14, 2018
·
8 min read
Pharm Country

WindRose Health Investors, LLC Announces Recapitalization of Traditions Behavioral Health

TBH manages all aspects of psychiatric staffing for its customers, including recruitment, on-boarding, training, scheduling, directorship, and documentation, among others.

November 14, 2018
·
3 min read
Business

CareCredit & MDsave Launch Strategic Partnership Helping Improve Access To Healthcare

Leading Healthcare Marketplace Offers Financing Options Designed to Help Customers Finance Healthcare Expenses

November 14, 2018
·
4 min read
Business

CASI Pharmaceuticals Announces Third Quarter and First Nine Months 2018 Financial and Business Results

Key new hires include Chief Financial Officer and President, CASI China as CASI prepares for global commercialization efforts

November 14, 2018
·
10 min read
FDA

FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease

Novel, one-time investigational treatment for CLN2 disease designed to halt progression of neurological decline

November 14, 2018
·
6 min read
Business

Concordia International Corp. Announces Third Quarter 2018 Results

Third quarter 2018 revenue of $128 million

November 14, 2018
·
33 min read
Business

RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

Appoints Gerrit Dispersyn as President and Chief Operating Officer, effective Today

November 14, 2018
·
11 min read
Pharm Country

Novartis to fund five innovative ideas to support patients and the sickle cell community

2018 STEP Program™ designed to support unique proposals from nonprofit organizations that serve people living with sickle cell disease

November 14, 2018
·
4 min read